BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Nirmal Bang Report
We hosted the JB Chemicals and Pharmaceuticals Ltd.'s management at our Annual Investor Conference to discuss the business outlook. The company remains poised for strong growth in the domestic business, which will be driven by growth in the base business and integration of acquisitions.
There is good visibility in the Lozenges CMO business too and the same should grow in mid-teens.
In the U.S. market, JB Chemicals will focus on manufacturing competency for building portfolio and remain conservative in its efforts, so as not to over invest. research and development investments will remain in the 3% range.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR